Study of QLS4131 for people with active lupus
Part of Immune system & allergy, Skin clinical trials.
This trial tests an investigational drug called QLS4131 in people with active systemic lupus erythematosus (SLE) who are already on standard treatments. The goal is to see if adding QLS4131 can help control lupus activity better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with lupus for at least 12 weeks.
- Your lupus is currently active (based on a standard score).
- You are on a stable dose of one or more standard lupus treatments (like steroids, antimalarials, or immunosuppressants).
- You do not have severe lupus kidney disease or other serious health problems listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, TQH3906, in people with systemic lupus erythematosus (SLE) who have moderate to severe disease activity. It aims to see if TQH3906 can safely reduce lupus symptoms like joint pain, skin rash, or vasculitis.
This early-stage study tests a new investigational drug called QLS2404 in healthy adults and in people with rheumatic autoimmune diseases such as lupus or Sjogren's syndrome. The goal is to see if the drug is safe and how the body handles it.
This trial tests a new drug called SHR-2173 for people with active lupus. It aims to see if it can reduce disease activity when taken with standard treatments.
This study tests an experimental daily pill (BI 3000202) for people with active lupus (SLE) to see if it can reduce disease activity. It compares different doses against a placebo, and you must already be on stable lupus background treatment.
This trial tests a new injection (CM313) to see if it can help people with active lupus. It's for those whose lupus symptoms aren't fully controlled despite standard treatments.
This study tests an oral tablet (TQB3702) for people with lupus. It aims to see if the drug can help control lupus activity. It's for patients already on standard lupus treatments with stable disease.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.